Diabetic Retinopathy Screening in the Yucatan Peninsula Using Smartphone-based Fundus Photography and Deep-learning Artificial Intelligence: A Field Study

Published in: Journal of Diabetes Science and Technology, 2023

Wroblewski, J.J., Sanchez-Buenfil, E., Inciarte, M., Berdia, J., Blake, L.R., Wroblewski, S., Patti, A., Suter, G., Sanborn, G.E.: "Diabetic Retinopathy Screening in the Yucatan Peninsula Using Smartphone-based Fundus Photography and Deep-learning Artificial Intelligence: A Field Study", Journal of Diabetes Science and Technology. 2023;0(0).DOI: 10.1177/19322968231194644

Abstract

Background:

To compare the performance of Medios (offline) and EyeArt (online) artificial intelligence (AI) algorithms for detecting diabetic retinopathy (DR) on images captured using fundus-on-smartphone photography in a remote outreach field setting.

Methods:

In June, 2019 in the Yucatan Peninsula, 248 patients, many of whom had chronic visual impairment, were screened for DR using two portable Remidio fundus-on-phone cameras, and 2130 images obtained were analyzed, retrospectively, by Medios and EyeArt. Screening performance metrics also were determined retrospectively using masked image analysis combined with clinical examination results as the reference standard.

Results:

A total of 129 patients were determined to have some level of DR; 119 patients had no DR. Medios was capable of evaluating every patient with a sensitivity (95% confidence intervals [CIs]) of 94% (88%-97%) and specificity of 94% (88%-98%). Owing primarily to photographer error, EyeArt evaluated 156 patients with a sensitivity of 94% (86%-98%) and specificity of 86% (77%-93%). In a head-to-head comparison of 110 patients, the sensitivities of Medios and EyeArt were 99% (93%-100%) and 95% (87%-99%). The specificities for both were 88% (73%-97%).

Conclusions:

Medios and EyeArt AI algorithms demonstrated high levels of sensitivity and specificity for detecting DR when applied in this real-world field setting. Both programs should be considered in remote, large-scale DR screening campaigns where immediate results are desirable, and in the case of EyeArt, online access is possible.